# National Bank Holdings Corp: financial statements, quarterly

NBHC · NYSE · CIK 1475841 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nbhc.md) · [Financials](/companies/nbhc/financials.md) · [Filings](/companies/nbhc/filings.md) · [Insiders](/companies/nbhc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nbhc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [13.0](/filings/0001475841-24-000054.md) | [10.5 d](/filings/0001104659-26-019119.md) | [11.0](/filings/0001475841-25-000022.md) | [11.7](/filings/0001475841-25-000044.md) | [12.1](/filings/0001475841-25-000063.md) | [11.4 d](/filings/0001104659-26-019119.md) | [10.8](/filings/0001475841-26-000027.md) | [11.1](/filings/0001104659-26-091272.md) | [11.3](/filings/0001475841-25-000063.md) | [13.9 d](/filings/0001104659-26-019119.md) | [11.4](/filings/0001475841-26-000027.md) | [11.9](/filings/0001104659-26-091272.md) |
| Interest expense | $m | [38.3](/filings/0001475841-23-000056.md) | [45.2 d](/filings/0001558370-24-001838.md) | [47.7](/filings/0001475841-24-000020.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [9.3](/filings/0001475841-24-000054.md) | [5.8 d](/filings/0001104659-26-019119.md) | [7.5](/filings/0001475841-25-000022.md) | [5.6](/filings/0001475841-25-000044.md) | [6.8](/filings/0001475841-25-000063.md) | [6.5 d](/filings/0001104659-26-019119.md) | [5.6](/filings/0001475841-26-000027.md) | [7.5](/filings/0001104659-26-091272.md) | [7.9](/filings/0001475841-25-000063.md) | [3.1 d](/filings/0001104659-26-019119.md) | [5.2](/filings/0001475841-26-000027.md) | [6.1](/filings/0001104659-26-091272.md) |
| Net income | $m | [36.1](/filings/0001475841-24-000054.md) | [33.1 d](/filings/0001104659-26-019119.md) | [31.4](/filings/0001475841-25-000022.md) | [26.1](/filings/0001475841-25-000044.md) | [33.1](/filings/0001475841-25-000063.md) | [28.2 d](/filings/0001104659-26-019119.md) | [24.2](/filings/0001475841-26-000027.md) | [34.0](/filings/0001104659-26-091272.md) | [35.3](/filings/0001475841-25-000063.md) | [16.0 d](/filings/0001104659-26-019119.md) | [20.8](/filings/0001475841-26-000027.md) | [26.5](/filings/0001104659-26-091272.md) |
| Diluted EPS | $ per share | [0.94](/filings/0001475841-24-000054.md) | not reported | [0.82](/filings/0001475841-25-000022.md) | [0.68](/filings/0001475841-25-000044.md) | [0.86](/filings/0001475841-25-000063.md) | not reported | [0.63](/filings/0001475841-26-000027.md) | [0.88](/filings/0001104659-26-091272.md) | [0.92](/filings/0001475841-25-000063.md) | not reported | [0.46](/filings/0001475841-26-000027.md) | [0.58](/filings/0001104659-26-091272.md) |
| Basic EPS | $ per share | [0.95](/filings/0001475841-24-000054.md) | not reported | [0.82](/filings/0001475841-25-000022.md) | [0.68](/filings/0001475841-25-000044.md) | [0.86](/filings/0001475841-25-000063.md) | not reported | [0.63](/filings/0001475841-26-000027.md) | [0.89](/filings/0001104659-26-091272.md) | [0.92](/filings/0001475841-25-000063.md) | not reported | [0.46](/filings/0001475841-26-000027.md) | [0.58](/filings/0001104659-26-091272.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0001475841-23-000056.md) | [0.2](/filings/0001558370-25-001502.md) | [0.3](/filings/0001475841-24-000020.md) | [0.1](/filings/0001475841-24-000038.md) | [0.2](/filings/0001475841-24-000054.md) | [0.1](/filings/0001104659-26-019119.md) | [0.2](/filings/0001475841-25-000022.md) | [0.3](/filings/0001475841-25-000044.md) | [0.6](/filings/0001475841-25-000063.md) | [0.4](/filings/0001104659-26-091272.md) | [0.5](/filings/0001475841-26-000027.md) | [0.4](/filings/0001104659-26-091272.md) |
| Total assets | $bn | [9.9](/filings/0001475841-23-000056.md) | [10.0](/filings/0001558370-25-001502.md) | [10.0](/filings/0001475841-24-000020.md) | [10.0](/filings/0001475841-24-000038.md) | [10.0](/filings/0001475841-24-000054.md) | [9.8](/filings/0001104659-26-019119.md) | [10.1](/filings/0001475841-25-000022.md) | [10.0](/filings/0001475841-25-000044.md) | [10.2](/filings/0001475841-25-000063.md) | [9.9](/filings/0001104659-26-091272.md) | [12.6](/filings/0001475841-26-000027.md) | [12.6](/filings/0001104659-26-091272.md) |
| Total liabilities | $bn | [8.7](/filings/0001475841-23-000056.md) | [8.7](/filings/0001558370-25-001502.md) | [8.7](/filings/0001475841-24-000020.md) | [8.7](/filings/0001475841-24-000038.md) | [8.7](/filings/0001475841-24-000054.md) | [8.5](/filings/0001104659-26-019119.md) | [8.8](/filings/0001475841-25-000022.md) | [8.6](/filings/0001475841-25-000044.md) | [8.8](/filings/0001475841-25-000063.md) | [8.5](/filings/0001104659-26-091272.md) | [10.9](/filings/0001475841-26-000027.md) | [10.9](/filings/0001104659-26-091272.md) |
| Long-term debt | $bn | [0.1](/filings/0001475841-23-000056.md) | [0.1](/filings/0001558370-25-001502.md) | [0.1](/filings/0001475841-24-000020.md) | [0.1](/filings/0001475841-24-000038.md) | [0.1](/filings/0001475841-24-000054.md) | [0.1](/filings/0001104659-26-019119.md) | [0.1](/filings/0001475841-25-000022.md) | [0.1](/filings/0001475841-25-000044.md) | [0.1](/filings/0001475841-25-000063.md) | [0.1](/filings/0001104659-26-091272.md) | [0.2](/filings/0001475841-26-000027.md) | [0.2](/filings/0001104659-26-091272.md) |
| Shareholders' equity | $bn | [1.2](/filings/0001475841-24-000054.md) | [1.2](/filings/0001104659-26-019119.md) | [1.2](/filings/0001475841-25-000044.md) | [1.2](/filings/0001475841-25-000063.md) | [1.3](/filings/0001475841-25-000063.md) | [1.3](/filings/0001104659-26-091272.md) | [1.3](/filings/0001104659-26-091272.md) | [1.4](/filings/0001104659-26-091272.md) | [1.4](/filings/0001475841-25-000063.md) | [1.4](/filings/0001104659-26-091272.md) | [1.7](/filings/0001104659-26-091272.md) | [1.7](/filings/0001104659-26-091272.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [48.1 d](/filings/0001475841-24-000054.md) | [44.6 d](/filings/0001104659-26-019119.md) | [30.0](/filings/0001475841-25-000022.md) | [31.9 d](/filings/0001475841-25-000044.md) | [47.0 d](/filings/0001475841-25-000063.md) | [46.4 d](/filings/0001104659-26-019119.md) | [39.6](/filings/0001475841-26-000027.md) | [32.3 d](/filings/0001104659-26-091272.md) | [52.4 d](/filings/0001475841-25-000063.md) | [38.1 d](/filings/0001104659-26-019119.md) | [(56.8)](/filings/0001475841-26-000027.md) | [135 d](/filings/0001104659-26-091272.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [9.9 d](/filings/0001475841-24-000054.md) | [10.3 d](/filings/0001104659-26-019119.md) | [10.3](/filings/0001475841-25-000022.md) | [10.8 d](/filings/0001475841-25-000044.md) | [10.7 d](/filings/0001475841-25-000063.md) | [11.1 d](/filings/0001104659-26-019119.md) | [11.3](/filings/0001475841-26-000027.md) | [11.5 d](/filings/0001104659-26-091272.md) | [11.4 d](/filings/0001475841-25-000063.md) | [11.8 d](/filings/0001104659-26-019119.md) | [14.7](/filings/0001475841-26-000027.md) | [14.5 d](/filings/0001104659-26-091272.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [8.8 d](/filings/0001475841-25-000063.md) | [2.1 d](/filings/0001104659-26-019119.md) | [16.1](/filings/0001475841-26-000027.md) | [11.1 d](/filings/0001104659-26-091272.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [31.5](/filings/0001475841-23-000056.md) | [38.1](/filings/0001475841-24-000020.md) | [38.1](/filings/0001475841-24-000038.md) | [38.1](/filings/0001475841-24-000054.md) | [38.2](/filings/0001475841-25-000022.md) | [38.4](/filings/0001475841-25-000044.md) | [38.5](/filings/0001475841-25-000063.md) | [38.2](/filings/0001475841-26-000027.md) | [38.2](/filings/0001104659-26-091272.md) | [38.0](/filings/0001475841-25-000063.md) | [44.6](/filings/0001475841-26-000027.md) | [44.9](/filings/0001104659-26-091272.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 44,539,547 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001104659-26-091272.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.